MuktaAroraMD

PubMed

• 1 citations
  The Prevalence of Pretransplant Frailty and Mental Distress in Hematopoietic Cell Transplantation and Association with Clinical Outcomes.
  Shivjot Singh, Qing Cao, Connor Demorest, Fiona He, Angela Kramer
  Transplantation and Cellular Therapy. 2024-09-01
• An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study.
  Aurore Perrot, Sosana Delimpasi, Emmanouil Spanoudakis, Ulf Frølund, Angelo Belotti
  Leukemia & Lymphoma. 2024-06-01
• 2 citations
  Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
  Catherine J Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas
  Transplantation and Cellular Therapy. 2024-01-01

Journal Articles

• Diffuse Alveolar Hemorrhage Is Most Often Fatal and Is Affected by Graft Source, Conditioning Regiment Toxicity, and Engraftment Kinetics  
  Erhan H Dincer, Erica D Warlick, Margaret L MacMillan, Patrick Arndt, Daniel J Weisdorf, Nelli Bejanyan, Claudio G Brunstein, Celalettin Ustun, Aleksandr Lazaryan, Ver..., Haematologica
• A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...  
  Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
• Late Mortality After Allogeneic Blood or Marrow Transplantation in Childhood for Leukemia: A Report from the Blood or Marrow Transplant Survivor Study-2  
  Stephen J Forman, Daniel J Weisdorf, Donna Salzman, Mukta Arora, Saro H Armenian, Nature

Abstracts/Posters

• Stroke Risk in Blood or Marrow Transplant (BMT) Survivors _ a Report from the BMT Survivor Study (BMTSS)
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Early Broad-Spectrum Antibiotics and Risk of Acute Graft-Versus-Host Disease in Children: An Analysis from the Center for International Blood and Marrow Transplantatio...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Burden of Long-Term Morbidity Borne By Survivors of Acute Myeloid Leukemia (AML) Treated with Blood or Marrow Transplantation (BMT) _ a Report from the BMT Survivor St...
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes of Chronic Graft-Versus-Host Disease (cGVHD) Following Matched Sibling Donor (MSD) Versus Umbilical Cord Blood Transplant (UCBT)
  Mukta Arora, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Burden of Morbidity Borne By Survivors of Multiple Myeloma (MM) Treated with Autologous Blood or Marrow Transplant (BMT) - Results of the BMT Survivor Study (BMTSS) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of T-Cell Dose on Gvhd Risk after Allogeneic HLA-Matched PBSC Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018